Login
Products
Login
Home
Alerts
Search
Watchlist
Products

Sanginita Chemicals Ltd

SANGINITA
NSE
20.64
1.98%
Last Updated:
29 Apr '26, 4:00 PM
Company Overview
Alert
Watchlist
Note

Sanginita Chemicals Ltd

SANGINITA
NSE
20.64
1.98%
29 Apr '26, 4:00 PM
Company Overview
Add Alert
Add to Watchlist
Edit Note
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
53Cr
Close
Close Price
20.64
Industry
Industry
Chemicals - Inorganic
PE
Price To Earnings
PS
Price To Sales
0.29
Revenue
Revenue
183Cr
Rev Gr TTM
Revenue Growth TTM
-21.27%
PAT Gr TTM
PAT Growth TTM
-3,877.78%
Peer Comparison
How does SANGINITA stack up?
Compare up to 10 companies side by side across valuation, profitability, and growth.
SANGINITA
VS

Quarterly Results

Standalone
Numbers
Percentage
QuarterMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Revenue
RevenueCr
343633295357616250464443
Growth YoY
Revenue Growth YoY%
-12.7-29.710.8-13.056.858.683.6111.0-6.0-19.4-28.1-29.4
Expenses
ExpensesCr
333532285356606049454445
Operating Profit
Operating ProfitCr
11110111110-2
OPM
OPM%
1.73.44.34.20.22.32.01.92.01.70.8-4.0
Other Income
Other IncomeCr
000000000000
Interest Expense
Interest ExpenseCr
111111111100
Depreciation
DepreciationCr
000000000111
PBT
PBTCr
0011-100000-1-3
Tax
TaxCr
000000000000
PAT
PATCr
0010-100000-1-3
Growth YoY
PAT Growth YoY%
79.2118.8800.058.6-480.0-11.4-59.3-69.691.4-64.5-409.1-2,085.7
NPM
NPM%
-0.31.01.61.6-1.10.50.40.2-0.10.2-1.5-6.4
EPS
EPS
-0.10.20.30.2-0.30.10.10.10.00.0-0.3-1.1

Profit & Loss

Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Revenue
RevenueCr
144147195188160165198149152230183
Growth
Revenue Growth%
2.232.0-3.6-14.83.020.3-25.02.051.6-20.2
Expenses
ExpensesCr
140142187178151161195146148225183
Operating Profit
Operating ProfitCr
55898433450
OPM
OPM%
3.23.34.14.95.22.41.42.02.62.00.2
Other Income
Other IncomeCr
00000001000
Interest Expense
Interest ExpenseCr
33233323322
Depreciation
DepreciationCr
10011111122
PBT
PBTCr
2255510111-3
Tax
TaxCr
11221000000
PAT
PATCr
1134310011-3
Growth
PAT Growth%
1.2208.914.2-14.6-77.3-54.419.685.0-19.6-649.7
NPM
NPM%
0.80.81.82.12.10.50.20.30.50.3-1.9
EPS
EPS
1.30.61.82.11.80.40.20.20.40.2-1.3

Balance Sheet

Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital
Equity CapitalCr
817171717171717172626
Reserves
ReservesCr
811141821222223243030
Current Liabilities
Current LiabilitiesCr
2631293639313637424545
Non Current Liabilities
Non Current LiabilitiesCr
11100042312
Total Liabilities
Total LiabilitiesCr
446061727870798086102102
Current Assets
Current AssetsCr
4056576774667570788788
Non Current Assets
Non Current AssetsCr
4445544981514
Total Assets
Total AssetsCr
446061727870798086102102

Cash Flow

Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating Cash Flow
Operating Cash FlowCr
0-731-29-314-23
Investing Cash Flow
Investing Cash FlowCr
00-1-1-10-1-1-4-10
Financing Cash Flow
Financing Cash FlowCr
08-202-84-1367
Net Cash Flow
Net Cash FlowCr
0000000000
Free Cash Flow
Free Cash FlowCr
0-820-28-413-6-6
CFO To PAT
CFO To PAT%
20.1-663.680.915.0-47.81,116.1-862.73,292.6-298.3529.8
CFO To EBITDA
CFO To EBITDA%
4.8-150.635.36.4-19.4219.0-109.6450.9-58.070.0

Ratios

Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
041901111273336333423
Price To Earnings
Price To Earnings
0.036.726.028.137.843.8104.579.043.337.5
Price To Sales
Price To Sales
0.00.30.50.60.80.20.20.20.20.1
Price To Book
Price To Book
0.01.52.93.13.30.80.90.80.80.4
EV To EBITDA
EV To EBITDA
5.513.414.615.219.516.025.820.216.810.6
Profitability Ratios
Profitability Ratios
GPM
GPM%
4.66.66.26.67.24.53.44.95.03.6
OPM
OPM%
3.23.34.14.95.22.41.42.02.62.0
NPM
NPM%
0.80.81.82.12.10.50.20.30.50.3
ROCE
ROCE%
10.38.713.313.410.65.33.44.45.04.0
ROE
ROE%
6.64.011.011.28.71.90.91.01.91.1
ROA
ROA%
2.51.95.75.54.31.10.40.50.90.6
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Sanginita Chemicals Limited is a Gujarat-based manufacturer of inorganic metal-based chemicals, currently undergoing a transformative pivot. Historically focused on copper derivatives, the company is transitioning into a diversified conglomerate with significant interests in renewable energy following a major change in corporate control and management. --- ### **Strategic Pivot: The Agastya Green Energy Integration** As of **March 2026**, Sanginita Chemicals is executing a fundamental shift in its business model, moving from a pure-play chemical manufacturer to an integrated energy and chemical platform. * **Acquisition of Agastya Green Energy Limited (AGEL):** The company is acquiring a **100% stake** in **AGEL** for **Rs. 19.95 Crore** (**95,00,000 shares at Rs. 21 per share**). This acquisition includes: * **Agastya Energy Industries Private Limited** (Wholly-owned subsidiary). * **BN UP Kusum Solar 1 Private Limited** and **IMC Solar BDN LLP** (Associate entities). * **Strategic Objective:** Entry into high-growth sectors including **Solar Panel Manufacturing**, **EPC (Engineering, Procurement, and Construction)**, and **Power Generation**. This diversification is intended to mitigate the sectoral risks inherent in the volatile chemical industry. * **Change in Control:** Following a **Share Swap and Share Purchase Agreement (SSSPA)** dated **March 20, 2026**, **B N G Investment LLC** and **Mr. Anubhav Agarwal** are set to become the new Promoters. * **Open Offer:** An offer has been extended to public shareholders to acquire **1,56,89,957 equity shares** (**26%** of the emerging voting capital) at **Rs. 13.55 per share**. Post-transaction, **B N G Investment LLC** is projected to hold **64.66%** of the expanded capital. --- ### **Core Chemical Operations & Manufacturing Infrastructure** Despite the diversification, the company maintains a robust manufacturing base for inorganic chemicals used in dyes, pigments, pharmaceuticals, and electroplating. * **Centralized Facility:** Operations are consolidated at **Unit II** in Chhatral, Gujarat, spanning **11,028 sq. meters**. * **Production Capacity:** | Product | Capacity (MT / P.A.) | | :--- | :--- | | **Copper Sulphate** | **8,400** (Expanded from 5,400 in June 2024) | | **Cuprous Chloride** | **6,000** | | **Cupric Chloride & Others** | **800** | * **Regulatory Standing:** Holds **GPCB** (Gujarat Pollution Control Board) consent for **45** chemical products, valid until **February 25, 2028**, with an authorized manufacturing limit of **8,700 MT per month**. * **Quality Standards:** **ISO 9001:2015** certified. The company operates an **in-house laboratory** for quality testing and process optimization, which is critical for maintaining industrial specifications and developing new product lines. --- ### **Financial Restructuring & Capital Allocation** The company has aggressively restructured its balance sheet to fund expansion and improve solvency. * **Capital Raising (2024-2026):** * **Rights Issue (June 2024):** Raised **Rs. 15.54 Crore** at **Rs. 18 per share**. Funds were deployed for working capital (**Rs. 6.59 Cr**), CAPEX (**Rs. 5.00 Cr**), and debt repayment. * **Preferential Issue (2026):** Issued **1,91,57,080 shares** at **Rs. 13.05** to raise **Rs. 24.99 Crore** in cash, alongside a share swap of **1,52,87,356 shares** for the AGEL acquisition. * **Expanded Limits:** Authorized capital was increased from **Rs. 27 Crore** to **Rs. 77 Crore** in March 2026. Borrowing and investment limits (Section 180/186) have both been raised to **Rs. 100 Crore**. * **Debt Profile:** The company utilized Rights Issue proceeds to reduce high-interest debt, significantly improving the **Debt-Equity Ratio**. However, it still carries **Rs. 305.30 Lakhs** in unsecured loans from the promoter group, repayable on demand. --- ### **Operational Efficiency & Financial Performance** While turnover has grown due to higher volumes and realization values, profitability remains sensitive to external cost pressures. **Comparative Financial Metrics:** | Metric | FY 2023-24 | FY 2022-23 | Variance Analysis | | :--- | :--- | :--- | :--- | | **Fixed Assets Turnover** | **27.01 Times** | **20.94 Times** | Improved asset utilization | | **Inventory Turnover** | **5.89 Times** | **7.77 Times** | Slower inventory cycle | | **Debtors Turnover** | **7.16 Times** | **9.12 Times** | Lengthening collection period | | **Interest Coverage** | **1.68 Times** | **2.03 Times** | Margin pressure vs. debt cost | * **Profitability Trends:** EBITDA and PAT have faced headwinds from **inflationary input costs** and increased **depreciation**. The company operates on a formula-based pricing model but often struggles to pass on 100% of raw material spikes (Copper, Nickel, Sulphuric Acid) to customers immediately. * **Asset Management:** The company follows a strict **no-capitalization-of-interest** policy for fixed assets and maintains a direct-to-customer model to eliminate intermediary costs. --- ### **Risk Matrix & Mitigation** Investors should note the following concentration and regulatory risks: * **Concentration Risks:** * **Revenue:** The **Top 10 customers** accounted for over **68%** of revenue in FY23. * **Supply:** The **Top 10 suppliers** account for approximately **70%** of raw material purchases. * **Commodity & Currency Exposure:** Raw materials are linked to global LME prices and **USD exchange rates**. The lack of long-term fixed-price supply contracts exposes the company to spot market volatility. * **Environmental & Safety Compliance:** Operations involve hazardous **Chlorine gas**. While GPCB consents are active until **2028**, any environmental non-compliance poses a threat to the "License to Operate." * **Governance & Continuity:** * The registered office lease expires on **December 31, 2026**. * There is currently **no non-compete agreement** with the former corporate promoter, **Sanginita Industries LLP**, which has similar business objects. * The company has a history of **delayed regulatory filings** regarding SEBI LODR and Takeover Regulations. --- ### **Future Outlook** The "New Sanginita" is positioned as a dual-engine entity. While the **Chemical Segment** focuses on increasing capacity utilization (currently at **~50%**) and leveraging the expanded Copper Sulphate line, the **Renewable Energy Segment** (via AGEL) is expected to become the primary driver of long-term valuation. The success of this transition depends on the seamless integration of the new management team and the effective deployment of the **Rs. 24.99 Crore** raised in the latest preferential round.